Nothing Special   »   [go: up one dir, main page]

SK22195A3 - Imidazo £1,2-a| pyridine derivatives, method of their production, pharmaceutical agents on their base, method of their production and their using - Google Patents

Imidazo £1,2-a| pyridine derivatives, method of their production, pharmaceutical agents on their base, method of their production and their using Download PDF

Info

Publication number
SK22195A3
SK22195A3 SK221-95A SK22195A SK22195A3 SK 22195 A3 SK22195 A3 SK 22195A3 SK 22195 A SK22195 A SK 22195A SK 22195 A3 SK22195 A3 SK 22195A3
Authority
SK
Slovakia
Prior art keywords
pyridin
imidazo
acid
group
tert
Prior art date
Application number
SK221-95A
Other languages
English (en)
Slovak (sk)
Inventor
Horst Juraszyk
Joachim Gante
Hans Wurziger
Sabine Bernstat-Danielowski
Guido Melzer
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK22195A3 publication Critical patent/SK22195A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK221-95A 1994-02-19 1995-02-17 Imidazo £1,2-a| pyridine derivatives, method of their production, pharmaceutical agents on their base, method of their production and their using SK22195A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4405378A DE4405378A1 (de) 1994-02-19 1994-02-19 Adhäsionsrezeptor-Antagonisten

Publications (1)

Publication Number Publication Date
SK22195A3 true SK22195A3 (en) 1995-09-13

Family

ID=6510687

Family Applications (1)

Application Number Title Priority Date Filing Date
SK221-95A SK22195A3 (en) 1994-02-19 1995-02-17 Imidazo £1,2-a| pyridine derivatives, method of their production, pharmaceutical agents on their base, method of their production and their using

Country Status (15)

Country Link
US (1) US5614531A (zh)
EP (1) EP0668278A1 (zh)
JP (1) JPH07252254A (zh)
KR (1) KR950032197A (zh)
CN (1) CN1111630A (zh)
AU (1) AU1230795A (zh)
CA (1) CA2142741A1 (zh)
CZ (1) CZ42495A3 (zh)
DE (1) DE4405378A1 (zh)
HU (1) HUT71806A (zh)
NO (1) NO950606L (zh)
PL (1) PL307328A1 (zh)
RU (1) RU95102323A (zh)
SK (1) SK22195A3 (zh)
ZA (1) ZA951345B (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199900781T2 (xx) * 1996-07-25 1999-07-21 Biogen, Inc. H�cre yap��ma inhibit�rleri
DE19653646A1 (de) * 1996-12-20 1998-06-25 Hoechst Ag Substituierte Purinderivate, Verfahren zu deren Herstellung, sie enthaltende Mittel und deren Verwendung
AR011057A1 (es) * 1997-01-08 2000-08-02 Smithkline Beecham Corp Uso de bis-acridinas sustituidas y compuestos afines para la preparacion de medicamentos y dichos compuestos
US5902797A (en) * 1997-11-10 1999-05-11 Beth Israel Deaconess Medical Center Nutritional supplement for use in the treatment of attention deficit
ATE322290T1 (de) 1998-12-23 2006-04-15 Searle Llc Verwendung von cyclooxygenase-2 inhibitor celecoxib und capecitabine zur kombinationsbehandlung von neoplasia
DE10117184A1 (de) * 2001-04-05 2002-10-17 Gruenenthal Gmbh Substituierte Imidazol[1,2-a]-pyridin-3-yl-amid- und -aminverbindungen
DE10117183A1 (de) * 2001-04-05 2002-10-10 Gruenenthal Gmbh Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel
ATE551060T1 (de) 2004-06-04 2012-04-15 Scripps Research Inst Zusammensetzungen und verfahren zur behandlung von neovaskulären erkrankungen
WO2006029258A2 (en) * 2004-09-07 2006-03-16 Archemix Corp. Aptamer medicinal chemistry
US7566701B2 (en) * 2004-09-07 2009-07-28 Archemix Corp. Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
CA2579374A1 (en) 2004-09-07 2006-03-30 Archemix Corp. Aptamers to von willebrand factor and their use as thrombotic disease therapeutics
US7919519B2 (en) * 2005-11-23 2011-04-05 Epix Pharmaceuticals Inc. S1P receptor modulating compounds and use thereof
US7855193B2 (en) * 2005-11-23 2010-12-21 Epix Pharmaceuticals, Inc. S1P receptor modulating compounds and use thereof
CA2631259A1 (en) * 2005-11-28 2007-06-07 Mallinckrodt Inc. Improved method of preparation for imidazolepyridines
JP2009530389A (ja) * 2006-03-21 2009-08-27 エピックス デラウェア， インコーポレイテッド Ｓ１ｐ受容体調節化合物及びその使用
US7563797B2 (en) * 2006-08-28 2009-07-21 Forest Laboratories Holding Limited Substituted imidazo(1,2-A)pyrimidines and imidazo(1,2-A) pyridines as cannabinoid receptor ligands
EP1964840A1 (en) 2007-02-28 2008-09-03 sanofi-aventis Imidazo[1,2-a]pyridines and their use as pharmaceuticals
AU2007227278B2 (en) * 2007-03-21 2014-09-11 Epix Pharmaceuticals, Inc. SIP receptor modulating compounds and use thereof
WO2008150495A2 (en) * 2007-06-01 2008-12-11 Archemix Corp. Vwf aptamer formulations and methods for use
MX2010002885A (es) * 2007-09-20 2010-04-01 Amgen Inc Derivados de acido 1-(4-(bencilbenzamido)-bencil)-azetidin-3-carbo xilico y compuestos relacionados como moduladores de receptores de s1p para el tratamiento de trastornos inmunitarios.
US7868001B2 (en) * 2007-11-02 2011-01-11 Hutchison Medipharma Enterprises Limited Cytokine inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593818B1 (fr) * 1986-02-05 1988-04-29 Synthelabo Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridine, leur preparation et leur application en therapeutique
DE3769333D1 (de) * 1986-01-22 1991-05-23 Synthelabo Acylaminomethylimidazo(1,2-a)pyrimidinderivate, ihre herstellung und therapeutische verwendung.
US4990506A (en) * 1986-02-05 1991-02-05 Synthelabo 3-(acylaminomethyl)imidazo[1,2-a]pyridine derivatives and their application in therapy
US4791117A (en) * 1986-09-22 1988-12-13 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo[1,2-a]pyridines and their use as calcium channel blockers
FR2606410B1 (fr) * 1986-11-07 1989-02-24 Synthelabo Imidazopyridines, leur preparation et leur application en therapeutique
US5053393A (en) * 1988-07-20 1991-10-01 Monsanto Company Novel platelet-aggregation inhibitor
US5256812A (en) * 1989-01-31 1993-10-26 Hoffmann-La Roche Inc. Carboxamides and sulfonamides
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
DE4017211A1 (de) * 1990-05-29 1991-12-05 Merck Patent Gmbh Oxazolidinone
WO1992019595A1 (en) * 1991-05-07 1992-11-12 Merck & Co., Inc. Fibrinogen receptor antagonists
US5321034A (en) * 1991-05-07 1994-06-14 Merck & Co., Inc. Fibrinogen receptor antagonists
DE4129603A1 (de) * 1991-09-06 1993-03-11 Thomae Gmbh Dr K Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5272158A (en) * 1991-10-29 1993-12-21 Merck & Co., Inc. Fibrinogen receptor antagonists
AU3648993A (en) * 1992-03-17 1993-10-21 Nippon Shinyaku Co. Ltd. Imidazopyridine derivative and medicine
DE4327027A1 (de) * 1993-02-15 1994-08-18 Bayer Ag Imidazoazine

Also Published As

Publication number Publication date
US5614531A (en) 1997-03-25
DE4405378A1 (de) 1995-08-24
HUT71806A (en) 1996-02-28
RU95102323A (ru) 1997-03-20
CZ42495A3 (en) 1995-10-18
CA2142741A1 (en) 1995-08-20
PL307328A1 (en) 1995-08-21
CN1111630A (zh) 1995-11-15
ZA951345B (en) 1995-10-24
KR950032197A (ko) 1995-12-20
NO950606L (no) 1995-08-21
AU1230795A (en) 1995-08-31
JPH07252254A (ja) 1995-10-03
EP0668278A1 (de) 1995-08-23
NO950606D0 (no) 1995-02-17
HU9500479D0 (en) 1995-04-28

Similar Documents

Publication Publication Date Title
SK22195A3 (en) Imidazo £1,2-a| pyridine derivatives, method of their production, pharmaceutical agents on their base, method of their production and their using
CA2122571C (en) Adhesion receptor antagonists
US6326403B1 (en) Diacylhydrazine derivatives as integrin inhibitors
SK78398A3 (en) Tyrosin-derivate as alpha-v-integrin inhibitors, method for the preparation thereof and pharmaceutical compositon containing same
SK282123B6 (sk) Derivát oxazolidinónu, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje
WO1997044333A1 (de) 1,2,4-oxadiazole as adhäsionsrezeptor-antagonisten
KR100462176B1 (ko) 점착성수용체길항제
CZ288122B6 (cs) Deriváty piperazinu, způsob jejich výroby a farmaceutické přípravky na jejich bázi
JP3810833B2 (ja) 接着レセプター拮抗薬
HU220042B (hu) Imidazopiridinszármazékok, eljárás ezek előállítására és ezeket tartalmazó gyógyászati készítmények
TW201326143A (zh) Ｇ蛋白偶合ｍａｓ受體之調節劑及與其相關病症之治療
KR20010086085A (ko) 이미다조[４,５-ｃ]-피리딘-４-온-유도체
WO1997002245A1 (fr) Derives de benzamidoxime et leur utilisation a des fins medicinales
SK281449B6 (sk) Derivát oxazolidinónu, spôsob jeho prípravy, farmaceutický prostriedok, ktorý ho obsahuje a použitie
SK14342001A3 (sk) Dibenzoazulénové deriváty na liečbu trombózy, osteoporózy, artériosklerózy
PL177772B1 (pl) Nowe związki, cyklopeptydy, sposób ich wytwarzania oraz preparat farmaceutyczny
CZ2001141A3 (cs) Derivát diacylhydrazinu jakožto integrinový inhibitor, způsob jeho přípravy, jeho použití a farmaceutický prostředek, který ho obsahuje